Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CARM holding history

Carisma Therapeutics Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CARM overviewAll 13F holders of CARMFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
18
Since Q1 2021
Holdings of CARM by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−293,686−100.0%Sold outHolders
Q3 2025293,686$80.5K<0.1%−35,600−10.8%ReducedHolders
Q2 2025329,286$128.9K<0.1%+75,629+29.8%AddedHolders
Q1 2025253,657$78.6K<0.1%+22,300+9.6%AddedHolders
Q4 2024231,357$96.9K<0.1%+24,600+11.9%AddedHolders
Q3 2024206,757$203.0K<0.1%+67,397+48.4%AddedHolders
Q2 2024139,360$211.8K<0.1%−86,635−38.3%ReducedHolders
Q1 2024225,995$513.0K<0.1%+12,961+6.1%AddedHolders
Q4 2023213,034$624.0K<0.1%+8,339+4.1%AddedHolders
Q3 2023204,695$866.0K<0.1%+102,935+101.2%AddedHolders
Q2 2023101,760$892.0K<0.1%+33,465+49.0%AddedHolders
Q1 202368,295$212.0K<0.1%+17,347+34.0%AddedConverted for a 1-for-20 splitHolders
Q4 20221,018,956$621.0K<0.1%−36,835−3.5%ReducedHolders
Q3 20221,055,791$449.0K<0.1%+441,791+72.0%AddedHolders
Q2 2022614,000$498.0K<0.1%+156,563+34.2%AddedHolders
Q1 2022457,437$276.0K<0.1%+457,437NewHolders
Q4 20210$00.0%−1,569,685−100.0%Sold outHolders
Q3 20211,569,685$1.25M<0.1%+301,088+23.7%AddedHolders
Q2 20211,268,597$5.86M<0.1%−2,479,300−66.2%ReducedHolders
Q1 20213,747,897$9.74M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.